TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

First Posted Date
2014-05-20
Last Posted Date
2021-11-09
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
882
Registration Number
NCT02141854
Locations
🇭🇺

Teva Investigational Site 51150, Nyíregyháza, Hungary

🇭🇺

Teva Investigational Site 51146, Szeged, Hungary

🇭🇺

Teva Investigational Site 51151, Nyíregyháza, Hungary

and more 151 locations

Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma

First Posted Date
2014-05-15
Last Posted Date
2021-11-12
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
787
Registration Number
NCT02139644
Locations
🇺🇸

Teva Investigational Site 12584, Longmont, Colorado, United States

🇺🇸

Teva Investigational Site 12379, Centennial, Colorado, United States

🇺🇸

Teva Investigational Site 12586, Fountain Valley, California, United States

and more 137 locations

A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics

First Posted Date
2014-04-30
Last Posted Date
2021-11-09
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
186
Registration Number
NCT02126839
Locations
🇺🇸

Teva Investigational Site 12510, Riverside, California, United States

🇺🇸

Teva Investigational Site 12526, Miami, Florida, United States

🇺🇸

Teva Investigational Site 12525, Cleveland, Ohio, United States

and more 49 locations

A Pharmacokinetic Study to Evaluate the Bioequivalence of 2 Progesterone Vaginal Rings in Postmenopausal Women

Phase 1
Completed
Conditions
Interventions
First Posted Date
2014-03-20
Last Posted Date
2021-11-09
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
56
Registration Number
NCT02092571
Locations
🇺🇸

Teva Investigational Site 12355, Miami, Florida, United States

A Phase I Study in Young Healthy Women to Investigate the Effects of Laquinimod on Standard Oral Contraceptive When Both Treatments Are Given Together

First Posted Date
2014-03-13
Last Posted Date
2021-11-09
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
40
Registration Number
NCT02085863
Locations
🇩🇪

Teva Investigational Site 32415, Moenchengladbach, Germany

A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2014-03-05
Last Posted Date
2021-11-09
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
10
Registration Number
NCT02078960
Locations
🇺🇸

Teva Investigational Site 12545, Jacksonville, Florida, United States

🇺🇸

Teva Investigational Site 12550, Atlanta, Georgia, United States

🇺🇸

Teva Investigational Site 12543, Indianapolis, Indiana, United States

and more 7 locations

A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee

Phase 2
Completed
Conditions
Interventions
First Posted Date
2014-02-21
Last Posted Date
2021-11-09
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
389
Registration Number
NCT02068599
Locations
🇺🇸

Teva Investigational Site 12236, Memphis, Tennessee, United States

🇺🇸

Teva Investigational Site 12246, Eustis, Florida, United States

🇺🇸

Teva Investigational Site 12255, Ormond Beach, Florida, United States

and more 39 locations

Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma

First Posted Date
2014-02-13
Last Posted Date
2024-03-22
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
485
Registration Number
NCT02062463
Locations
🇬🇧

Teva Investigational Site 34111, Colchester, United Kingdom

🇬🇧

Teva Investigational Site 34105, Stanley, United Kingdom

🇬🇧

Teva Investigational Site 34117, Stalham, United Kingdom

and more 71 locations

A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia

First Posted Date
2014-01-23
Last Posted Date
2022-06-08
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
101
Registration Number
NCT02044276
Locations
🇮🇹

Teva Investigational Site 30059, Milano, Italy

🇩🇪

Teva Investigational Site 32275, Koeln, Germany

🇩🇪

Teva Investigational Site 32284, Aurich, Germany

and more 57 locations

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

First Posted Date
2014-01-20
Last Posted Date
2021-11-09
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Target Recruit Count
628
Registration Number
NCT02040766
Locations
🇺🇸

Teva Investigational Site 10894, Aventura, Florida, United States

🇺🇸

Teva Investigational Site 12332, Winter Park, Florida, United States

🇺🇸

Teva Investigational Site 10916, Rolla, Missouri, United States

and more 99 locations
© Copyright 2024. All Rights Reserved by MedPath